Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients
F Jehl, C Muller-Serieys, V De Larminat… - Antimicrobial agents …, 1994 - Am Soc Microbiol
… occur in bronchial secretions after multiple doses. Whereas our data concerning the
penetration of tazobactam into bronchial secretions are unique so far, other data on piperacillin do …
penetration of tazobactam into bronchial secretions are unique so far, other data on piperacillin do …
Piperacillin/tazobactam in the treatment of lower respiratory tract infections: an open non-comparative and multicentered trial
J Sifuentes-Osornio, GM Ruíz-Palacios… - Journal of …, 1994 - Taylor & Francis
… a culture and Gram stain of respiratory secretions obtained by expectoration, endotracheal
… 48 h prior to starting piperacillintazobactam. The Gram stain of respiratory secretions should …
… 48 h prior to starting piperacillintazobactam. The Gram stain of respiratory secretions should …
… study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam …
F Varotto, GD Maria, R Azzaro, P Bellissima… - Journal of …, 2001 - Taylor & Francis
… this problem by carefully directing swabs on visible secretions in the oropharyngeal cavity. …
We found in this study that both piperacillin and piperacillin/tazobactam are more active than …
We found in this study that both piperacillin and piperacillin/tazobactam are more active than …
Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection
DM Shlaes, R Baughman, CT Boylen… - Journal of …, 1994 - academic.oup.com
… We attempted to examine antibiotic efficacy only in bacterial infection by requiring that a
Gram's stain of respiratory secretions was positive before patients could be entered into the study…
Gram's stain of respiratory secretions was positive before patients could be entered into the study…
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection
M Joshi, J Bernstein, J Solomkin… - Journal of …, 1999 - academic.oup.com
… In this study, piperacillin/tazobactam plus tobramycin was shown to be more effective and …
of respiratory secretions were obtained before the start of treatment. Respiratory secretions …
of respiratory secretions were obtained before the start of treatment. Respiratory secretions …
Efficacy and Safety Analysis of Piperacillin Tazobactam in Combination With High Frequency Chest Wall Oscillation in Patients With COPD Coupled With Pneumonia
QM MM, FL MM - Alternative Therapies in Health and Medicine, 2023 - search.proquest.com
… and effectively expel secretions produced by alveoli, deep small bronchi, main bronchi, and
trachea… the effectiveness and safety of piperacillin tazobactam in combination with the use of …
trachea… the effectiveness and safety of piperacillin tazobactam in combination with the use of …
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
L Lorente, A Jiménez, MM Martín, JL Iribarren… - International journal of …, 2009 - Elsevier
… from respiratory secretions (tracheal aspirate >10 6 colony-forming units/mL) or isolation of
the same microorganism in blood and respiratory secretions. The respiratory microbiological …
the same microorganism in blood and respiratory secretions. The respiratory microbiological …
Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia
… Our results show great variability in piperacillin/tazobactam concentrations, with an
alveolar percentage penetration of 40–50% for piperacillin and 65–85% for tazobactam and a …
alveolar percentage penetration of 40–50% for piperacillin and 65–85% for tazobactam and a …
Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia
… ±1.2 µg/ml for tazobactam, respectively. The mean±… piperacillin and 2.1±1.1 µg/ml for
tazobactam, respectively, showing a mean percentage penetration of piperacillin and tazobactam …
tazobactam, respectively, showing a mean percentage penetration of piperacillin and tazobactam …
Piperacillin-tazobactam-induced fever in chronic respiratory diseases: Safe challenge test under premedication
M Ramassamy, M Murris, I Recoche, C Mailhol… - Revue Française d' …, 2022 - Elsevier
… piperacillin-tazobactam-induced fever with a safe re-exposure to this antibiotic with a
premedication. This antibiotic was used to eradicate or to treat infection of PA in chronic respiratory …
premedication. This antibiotic was used to eradicate or to treat infection of PA in chronic respiratory …
相关搜索
- piperacillin tazobactam clinical outcomes
- piperacillin tazobactam beta lactam
- piperacillin tazobactam intensive care patients
- piperacillin tazobactam nosocomial pneumonia
- comparative activity of piperacillin tazobactam
- piperacillin tazobactam tract infection
- piperacillin tazobactam randomized controlled trial
- piperacillin tazobactam continuous infusion
- piperacillin tazobactam in the treatment
- piperacillin tazobactam β lactam
- piperacillin tazobactam clinical studies
- piperacillin tazobactam chronic respiratory diseases
- piperacillin tazobactam in combination
- alternative dosing strategies for piperacillin tazobactam
- piperacillin tazobactam in adults
- piperacillin tazobactam in an elderly patient